Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells

Remdesivir (RDV) has generated much anticipation for its moderate effect in treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the unsatisfactory survival rates of hospitalized patients limit its application to the treatment of coronavirus disease 2019 (COVID-1...

Full description

Bibliographic Details
Main Authors: Yan Li, Hui-Xia Zhang, Wen-Di Luo, Christopher Wai Kei Lam, Cai-Yun Wang, Li-Ping Bai, Vincent Kam Wai Wong, Wei Zhang, Zhi-Hong Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.647280/full
id doaj-e3198f431c524ce6a6999b6506e5e6b9
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yan Li
Hui-Xia Zhang
Wen-Di Luo
Christopher Wai Kei Lam
Cai-Yun Wang
Li-Ping Bai
Vincent Kam Wai Wong
Wei Zhang
Zhi-Hong Jiang
spellingShingle Yan Li
Hui-Xia Zhang
Wen-Di Luo
Christopher Wai Kei Lam
Cai-Yun Wang
Li-Ping Bai
Vincent Kam Wai Wong
Wei Zhang
Zhi-Hong Jiang
Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
Frontiers in Pharmacology
remdesivir
perturbation of nucleotide pools
inhibition of RNA and DNA synthesis
inhibition of CTP synthase
cell cycle arrest
Covid-19 therapy
author_facet Yan Li
Hui-Xia Zhang
Wen-Di Luo
Christopher Wai Kei Lam
Cai-Yun Wang
Li-Ping Bai
Vincent Kam Wai Wong
Wei Zhang
Zhi-Hong Jiang
author_sort Yan Li
title Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
title_short Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
title_full Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
title_fullStr Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
title_full_unstemmed Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial Cells
title_sort profiling ribonucleotide and deoxyribonucleotide pools perturbed by remdesivir in human bronchial epithelial cells
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-05-01
description Remdesivir (RDV) has generated much anticipation for its moderate effect in treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the unsatisfactory survival rates of hospitalized patients limit its application to the treatment of coronavirus disease 2019 (COVID-19). Therefore, improvement of antiviral efficacy of RDV is urgently needed. As a typical nucleotide analog, the activation of RDV to bioactive triphosphate will affect the biosynthesis of endogenous ribonucleotides (RNs) and deoxyribonucleotides (dRNs), which are essential to RNA and DNA replication in host cells. The imbalance of RN pools will inhibit virus replication as well. In order to investigate the effects of RDV on cellular nucleotide pools and on RNA transcription and DNA replication, cellular RNs and dRNs concentrations were measured by the liquid chromatography-mass spectrometry method, and the synthesis of RNA and DNA was monitored using click chemistry. The results showed that the IC50 values for BEAS-2B cells at exposure durations of 48 and 72 h were 25.3 ± 2.6 and 9.6 ± 0.7 μM, respectively. Ten (10) μM RDV caused BEAS-2B arrest at S-phase and significant suppression of RNA and DNA synthesis after treatment for 24 h. In addition, a general increase in the abundance of nucleotides and an increase of specific nucleotides more than 2 folds were observed. However, the variation of pyrimidine ribonucleotides was relatively slight or even absent, resulting in an obvious imbalance between purine and pyrimidine ribonucleotides. Interestingly, the very marked disequilibrium between cytidine triphosphate (CTP) and cytidine monophosphate might result from the inhibition of CTP synthase. Due to nucleotides which are also precursors for the synthesis of viral nucleic acids, the perturbation of nucleotide pools would block viral RNA replication. Considering the metabolic vulnerability of endogenous nucleotides, exacerbating the imbalance of nucleotide pools imparts great promise to enhance the efficacy of RDV, which possibly has special implications for treatment of COVID-19.
topic remdesivir
perturbation of nucleotide pools
inhibition of RNA and DNA synthesis
inhibition of CTP synthase
cell cycle arrest
Covid-19 therapy
url https://www.frontiersin.org/articles/10.3389/fphar.2021.647280/full
work_keys_str_mv AT yanli profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT huixiazhang profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT wendiluo profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT christopherwaikeilam profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT caiyunwang profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT lipingbai profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT vincentkamwaiwong profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT weizhang profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
AT zhihongjiang profilingribonucleotideanddeoxyribonucleotidepoolsperturbedbyremdesivirinhumanbronchialepithelialcells
_version_ 1721497819393556480
spelling doaj-e3198f431c524ce6a6999b6506e5e6b92021-04-30T13:28:20ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-05-011210.3389/fphar.2021.647280647280Profiling Ribonucleotide and Deoxyribonucleotide Pools Perturbed by Remdesivir in Human Bronchial Epithelial CellsYan Li0Hui-Xia Zhang1Wen-Di Luo2Christopher Wai Kei Lam3Cai-Yun Wang4Li-Ping Bai5Vincent Kam Wai Wong6Wei Zhang7Zhi-Hong Jiang8State Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaFaculty of Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaState Key Laboratory of Quality Research in Chinese Medicines, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Disease (Macau University of Science and Technology), Taipa, Macau, ChinaRemdesivir (RDV) has generated much anticipation for its moderate effect in treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the unsatisfactory survival rates of hospitalized patients limit its application to the treatment of coronavirus disease 2019 (COVID-19). Therefore, improvement of antiviral efficacy of RDV is urgently needed. As a typical nucleotide analog, the activation of RDV to bioactive triphosphate will affect the biosynthesis of endogenous ribonucleotides (RNs) and deoxyribonucleotides (dRNs), which are essential to RNA and DNA replication in host cells. The imbalance of RN pools will inhibit virus replication as well. In order to investigate the effects of RDV on cellular nucleotide pools and on RNA transcription and DNA replication, cellular RNs and dRNs concentrations were measured by the liquid chromatography-mass spectrometry method, and the synthesis of RNA and DNA was monitored using click chemistry. The results showed that the IC50 values for BEAS-2B cells at exposure durations of 48 and 72 h were 25.3 ± 2.6 and 9.6 ± 0.7 μM, respectively. Ten (10) μM RDV caused BEAS-2B arrest at S-phase and significant suppression of RNA and DNA synthesis after treatment for 24 h. In addition, a general increase in the abundance of nucleotides and an increase of specific nucleotides more than 2 folds were observed. However, the variation of pyrimidine ribonucleotides was relatively slight or even absent, resulting in an obvious imbalance between purine and pyrimidine ribonucleotides. Interestingly, the very marked disequilibrium between cytidine triphosphate (CTP) and cytidine monophosphate might result from the inhibition of CTP synthase. Due to nucleotides which are also precursors for the synthesis of viral nucleic acids, the perturbation of nucleotide pools would block viral RNA replication. Considering the metabolic vulnerability of endogenous nucleotides, exacerbating the imbalance of nucleotide pools imparts great promise to enhance the efficacy of RDV, which possibly has special implications for treatment of COVID-19.https://www.frontiersin.org/articles/10.3389/fphar.2021.647280/fullremdesivirperturbation of nucleotide poolsinhibition of RNA and DNA synthesisinhibition of CTP synthasecell cycle arrestCovid-19 therapy